Annexon ANNX Stock
Annexon Price Chart
Annexon ANNX Financial and Trading Overview
| Annexon stock price | 3.94 USD |
| Previous Close | 4.14 USD |
| Open | 4.16 USD |
| Bid | 3.94 USD x 100 |
| Ask | 5.08 USD x 200 |
| Day's Range | 3.92 - 4.19 USD |
| 52 Week Range | 2.32 - 7.18 USD |
| Volume | 3.94M USD |
| Avg. Volume | 3.57M USD |
| Market Cap | 746.94M USD |
| Beta (5Y Monthly) | 1.215 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.29 USD |
ANNX Valuation Measures
| Enterprise Value | 600.27M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.6402273 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.6960602 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.881 |
Trading Information
Annexon Stock Price History
| Beta (5Y Monthly) | 1.215 |
| 52-Week Change | 71.07% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 7.18 USD |
| 52 Week Low | 2.32 USD |
| 50-Day Moving Average | 5.31 USD |
| 200-Day Moving Average | 5.4 USD |
ANNX Share Statistics
| Avg. Volume (3 month) | 3.57M USD |
| Avg. Daily Volume (10-Days) | 2.58M USD |
| Shares Outstanding | 189.58M |
| Float | 163.79M |
| Short Ratio | 12.6 |
| % Held by Insiders | 0.42% |
| % Held by Institutions | 102.93% |
| Shares Short | 32.09M |
| Short % of Float | 17.91% |
| Short % of Shares Outstanding | 16.92% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.54% |
| Return on Equity (ttm) | -105.26% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -208388000 USD |
| Net Income Avi to Common (ttm) | -202668000 USD |
| Diluted EPS (ttm) | -1.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 209.24M USD |
| Total Cash Per Share (mrq) | 1.1 USD |
| Total Debt (mrq) | 24.65M USD |
| Total Debt/Equity (mrq) | 13.25 USD |
| Current Ratio (mrq) | 5.529 |
| Book Value Per Share (mrq) | 1.066 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -193032992 USD |
| Levered Free Cash Flow (ttm) | -115986496 USD |
Profile of Annexon
| Country | United States |
| State | CA |
| City | Brisbane |
| Address | 1400 Sierra Point Parkway |
| ZIP | 94005 |
| Phone | 650 822 5500 |
| Website | https://www.annexonbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 92 |
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Q&A For Annexon Stock
What is a current ANNX stock price?
Annexon ANNX stock price today per share is 3.94 USD.
How to purchase Annexon stock?
You can buy ANNX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Annexon?
The stock symbol or ticker of Annexon is ANNX.
Which industry does the Annexon company belong to?
The Annexon industry is Biotechnology.
How many shares does Annexon have in circulation?
The max supply of Annexon shares is 189.58M.
What is Annexon Price to Earnings Ratio (PE Ratio)?
Annexon PE Ratio is now.
What was Annexon earnings per share over the trailing 12 months (TTM)?
Annexon EPS is -1.13 USD over the trailing 12 months.
Which sector does the Annexon company belong to?
The Annexon sector is Healthcare.
Annexon ANNX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26333.04 USD — |
+0.96
|
5.66B USD — | 26283.11 USD — | 26431.22 USD — | — - | 5.66B USD — |
|
US Tech Biotechnology
NBI
US
|
6924.69 USD — |
+0.05
|
— — | 6924.47 USD — | 7006.06 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1293.65 USD — |
+0.08
|
— — | 1293.64 USD — | 1310.12 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12940.54 USD — |
+0.98
|
— — | 12913.4 USD — | 12988.37 USD — | — - | — — |
- {{ link.label }} {{link}}
